MERCAPTOPURINE (is an active metabolite) | MERCAPTOPURINE | ATC L01BB02
ANTINEOPLASTIC TREATMENT OF ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) (DRUG FOR RARE DISEASE IN EUROPE) ANTIMETABOLITES IMMUNOSUPPRESSIVE AGENTS NUCLEIC ACID SYNTHESIS INHIBITORS PURINE ANALOGUES MODIFIED BY HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE (HGPRT) TO TIMP (THIOINOSINE MONOPHOSPHATE) AND THEN DIVERSES KINASES (INOSINE MONOPHOSPHATE DEHYDROGENASE, GUANOSINE MONOPHOSPHATE SYNTHETASE AND KINASES) WHICH LEAD TO THE INCORPORATION OF 6-THIOGUANINE NUCLEOTIDES (6-TGN) INTO DNA | ORAL | VD 65 LITER (65 KILOGRAM) PPB 15 PERCENT Cl 58.5 LITER / HOUR (65 KILOGRAM) HT 1 HOUR | HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE (HGPRT) | Amidophosphoribosyltransferase UNIPROT Q06203 PPAT more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |